SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-026440
Filing Date
2018-10-09
Accepted
2018-10-09 17:11:00
Documents
1
Period of Report
2018-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7989
  Complete submission text file 0000899243-18-026440.txt   9307
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2071 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
FISHMAN ROBERT S (Reporting) CIK: 0001232237 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 181114319